• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EASYTRAK 2 IS-1; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EASYTRAK 2 IS-1; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number 4542
Device Problems Failure to Capture (1081); High impedance (1291); Failure to Select Signal (1582); Device Dislodged or Dislocated (2923); Material Integrity Problem (2978); High Capture Threshold (3266)
Patient Problem Dyspnea (1816)
Event Date 05/01/2018
Event Type  Injury  
Manufacturer Narrative
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event Description
It was reported that, during a routine follow-up, this left ventricular (lv) lead exhibited loss of capture at maximum outputs and high out of range pacing impedances.Sensing amplitudes had also decreased since the previous check and a lead fracture was suspected.The patient reported feeling slightly more breathless but no other adverse patient effects were reported.The patient was to be scheduled for a chest x-ray.This lv lead remains in service.No adverse patient effects were reported.
 
Event Description
It was reported that, during a routine follow-up, this left ventricular (lv) lead exhibited loss of capture at maximum outputs and high out of range pacing impedances.Sensing amplitudes had also decreased since the previous check and a lead fracture was suspected.The patient reported feeling slightly more breathless but no other adverse patient effects were reported.The patient was to be scheduled for a chest x-ray.This lv lead remains in service.No adverse patient effects were reported.New information received indicates that the chest x-ray confirmed dislodgement the patient underwent surgical intervention to replace the lv lead however due to a blocked superior vena cava (svc) a new lead could not be implanted.The procedure was halted and the patient was scheduled for an svc stent/balloon procedure with a vascular surgeon.In the meantime the patient's health deteriorated which is not believed to be related to this lv lead malfunction.The associated device was deactivated and the patient is under palliative care.
 
Manufacturer Narrative
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EASYTRAK 2 IS-1
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key8712569
MDR Text Key148437359
Report Number2124215-2019-11102
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526410901
UDI-Public00802526410901
Combination Product (y/n)N
PMA/PMN Number
P010012/S024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/19/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date02/21/2008
Device Model Number4542
Device Catalogue Number4542
Was Device Available for Evaluation? No
Date Manufacturer Received07/05/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age90 YR
-
-